Abstract
Background
Tubulointerstitial nephritis (TIN) is an uncommon condition in which the aetiology, treatment and outcome is not well defined. We describe a large series of children with biopsy-proven TIN.
Methods
All children with biopsy-proven TIN presenting to our institution during a 23-year period were retrospectively reviewed for aetiology, symptoms, treatment, and long-term outcome.
Results
A total of 27 children (16 girls) were described. Median age was 12 years (range 8 months to 15 years). A potentially adverse drug reaction was found in 12 (44 %) and infection in 8 (30 %). In 13 (48 %) no initiating factor was identified. All but 1 patient were treated with corticosteroids owing to worsening kidney function and 4 patients with other immunosuppressive agents. Fifteen children (56 %) had an estimated glomerular filtration rate (eGFR) of less than 80 ml/min/1.73 m2 at last follow-up. Fifteen of the 23 children investigated (65 %) had coexistent uveitis.
Conclusion
This series represents a subset of paediatric TIN patients in whom there was a clinical indication for a renal biopsy, hence presenting with more severe disease than previously reported. This group were more likely to have no identifiable underlying cause and an increased requirement for corticosteroid treatment. Furthermore, more than half of the cases developed chronic kidney disease (CKD) with impaired kidney function.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Acute tubulointerstitial nephritis (TIN) was first described by Biemer in 1860, and defined as a disease entity by Councilman in 1898, noting histopathological changes in autopsy specimens of patients with diphtheria and scarlet fever (described in Kodner and Kudrimoti and Schwarz et al. [1, 2]).
Tubulointerstitial nephritis is a significant cause of acute kidney injury (AKI) among children and adults that accounts for 5–15 % of cases of acute kidney injury (AKI), in some patients leading to chronic kidney disease (CKD) [3]. Approximately 1 % of renal biopsies performed for the evaluation of haematuria or proteinuria show TIN and it was reported in 3–7 % of biopsies from children with AKI [4, 5].
One major cause of acute TIN is as a complication of drug treatment, often antibiotics, mainly ß-lactam and rifampicin, but also analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) and diuretics [2]. Acute TIN has also been described in association with infections, autoimmune or collagen vascular disorders and systemic diseases. It may present as granulomatous inflammation in sarcoidosis or as part of the syndrome of TIN and uveitis (TINU) [6, 7].
The original description of TIN included the triad of fever, eosinophilia and a rash. Recent studies suggest that this triad might be present in only around 30 % of cases [8]. Acute TIN is often associated with non-specific signs and symptoms, such as low-grade fever, maculopapular rash, mild arthralgia, anorexia, nausea, vomiting, abdominal or loin pain and malaise [1, 5].
Information on aetiology, clinical presentation and outcome of acute TIN in the paediatric setting is limited. The aim of this study is therefore to describe the clinical features and outcomes of children with biopsy-proven TIN.
Materials and methods
We performed a retrospective review of the case notes of all children younger than 18 years, with a proven histological diagnosis of TIN at Great Ormond Street Hospital GOSH for Children, London, between January 1990 and November 2012. Patients with a kidney transplant, a defined underlying glomerular disease or inherited renal disease were excluded.
Data on previous infections and medications, clinical signs and symptoms, ultrasound features and abnormalities on urinalysis and tubular function tests at presentation were collected. Maximum serum creatinine and estimated glomerular filtration rate (eGFR) at the time of presentation and at the latest clinical control, treatment received and concurrence of uveitis were also recorded. The eGFR was determined according to the Schwartz formula, using a k value of 33 [9].
The indication for kidney biopsy was impaired kidney function that did not improve on stopping the suspected causative drug. The database and descriptive statistics were created in Microsoft Excel for Mac 2011. Linear regression was performed on Infostat 2007 and Wilcoxon signed rank test was performed on Prism 6. The study was registered with the clinical governance and safety team at Great Ormond Street Hospital for Children.
Results
There were 27 children with biopsy-proven TIN during the 23-year study period including 11 boys and 16 girls, aged between 8 months and 15 years (median 12 years; Table 1).
Potential causative factors
Twenty-five of the children (93 %) had an unremarkable previous medical history. One patient, who had been previously diagnosed with an undefined immunodeficiency, developed bronchiectasis (patient number 7, Table 1). Another patient, whose mother had been diagnosed with sarcoidosis during childhood, had been followed for erythema nodosum and chronic uveitis during infancy and had been later diagnosed with sarcoidosis on renal biopsy (patient number 20, Table 1).
Twelve (44 %) of the children had recently received one or more medications, including non-steroidal anti-inflammatory drugs, aspirin, paracetamol, antibiotics, H2 blockers and proton pump inhibitors. Of those patients, 1 was receiving chronic omeprazole and antibiotic prophylaxis because of immunodeficiency and bronchiectasis (patient number 7). The other 11 children had 1–12 weeks between the drug exposure and the development of symptoms. Eight children had a previous infection: 6 (24 %) had a respiratory tract infection, 1 had diarrhoea and another had endocarditis caused by Staphylococcus aureus. This latter child was treated for 6 weeks with vancomycin. Thus, in 13 children (48 %) no potential causative factor could be identified.
Clinical presentation
The duration of the symptoms before the presentation at GOSH was a median of 5 (range 0.3–12) weeks. Twenty-six patients showed non-specific symptoms, the most common being anorexia, malaise and vomiting (Table 2). The boy with uveitis and a family history of sarcoidosis was the only child who was asymptomatic at the time of diagnosis.
Proteinuria was found in 96 % of the children. Only patient number 7 developed a nephrotic range of 698 mg/mmol without other features of nephrotic syndrome. The other children had a median urine albumin/creatinine ratio of 16.5 (range 4.4–43.7) mg/mmol. Pyuria and microscopic haematuria were present in 21 out of 27 (each) patients (78 %) and glycosuria was found in 17 out of 21 of the children tested (81 %). Urine potassium wasting was present in 7 out of 10 children, phosphorus tubular reabsorption was less than 85 % in 8 out of the 13 evaluated patients and metabolic acidosis was present in 7 out of 26 of the children tested. Low molecular weight urine proteins, the urinary N-Acetyl-beta-D-glucosaminidase:creatinine ratio (U-NAG/Cr) and retinol binding protein:creatinine ratio (U-RBP/Cr), were abnormally high in 17 of the 18 children tested. Median U-NAG/Cr was 189 (range 7–378; normal range 3.5–27.3) U/mmol and the median U-RBP/Cr was 4,257 (range 87–21,827; normal range 1.9–42.6) μg/mmol (Table 3).
Twenty-six patients had been investigated using renal ultrasound, 14 of whom had abnormal findings, including kidney enlargement and/or increased echogenicity (Table 2).
Initial kidney function
The maximum serum creatinine was a median of 263 (35–1,143) μmol/l, median eGFR was 20 (4.6–103.7) ml/min/1.73 m2. The eGFR was less than 10 ml/min/1.73 m2 in 5 patients and 4 of them required renal replacement therapy (1 peritoneal dialysis and 3 haemodialysis). We found no relation between the time to onset of treatment or if the steroids were given orally or as large intravenous doses and the outcome regarding kidney function. There was no difference in the severity of disease between the children with and those without uveitis.
Treatment
Twenty-six children received steroid therapy: 18 received intravenous methylprednisolone followed by oral prednisone, 6 were given oral prednisone from the beginning and 2 received intravenous methylprednisolone as the only steroid treatment (Table 1). Only 1 child did not receive any steroid therapy; he was admitted after 1 week of diarrhoea and vomiting after treatment with ceftriaxone and metronidazole and developed anuric AKI requiring peritoneal dialysis for 5 days. When the biopsy result was available he had recovered and did not need any further therapy. Three patients required further immunosuppressive therapy with azathioprine.
Follow-up
Twenty-five children were followed for a median of 21 (1–128) months. The kidney function improved in all children to a median eGFR of 75.7 (44.4–116.3) ml/min/1.73 m2. Fifteen patients had an eGFR below 80 ml/min/1.73 m2 at last follow-up (Table 1). Figure 1 shows the improvement in kidney function on treatment (p value <0.0001). Two children showed one relapse each, 2 and 4 months after the first episode respectively. Four patients had low-grade proteinuria (urine albumin/creatinine ratio range of 4.3–9.2 mg/mmol), 1 child had high-grade proteinuria (urine albumin/creatinine ratio of 310 mg/mmol) and 3 children had hypertension at follow-up. Fourteen of the 18 patients were tested for low molecular weight urine proteins with follow-up ranging from 2 months to 10 years. Those 14 children showed lower but not normalised urinary levels of NAG, with a median NAG/Cr of 30 (7–148) U/mmol, and RBP with a median RBP/Cr of 31.5 (2–524) μg/mmol (Table 3).
Uveitis
Twenty-three children were examined by an ophthalmologist and 15 (65 %) were diagnosed with uveitis. Eight of these did not have any eye symptoms. The uveitis was diagnosed at onset in 6 children, in 3 children, 3 to 12 months before TIN and in 6 children 1 to 20 months after TIN. Eleven children were treated with steroid eye drops and 4 with systemic steroids, which had already been given for the TIN. Two children also required other immunosuppressant therapies because of active uveitis. One boy developed sensorineural hearing loss, confirming the diagnosis of atypical Cogan syndrome, and received further treatment with azathioprine followed by mycophenolate mofetil. Another girl had a recurrent course of uveitis and was treated with local and systemic steroids followed by methotrexate, cyclosporine and adalimumab (Table 1). In 5 children the uveitis resolved, and 6 had a relapsing course, including the patient diagnosed with sarcoidosis and the child with atypical Cogan syndrome.
Discussion
We describe a series of 27 children with biopsy-proven TIN from a specialist centre. A potential cause was found in only 13 (48 %) patients. Sixty per cent of the children had an eGFR of less than 80 ml/min/1.73 m2 at the last available follow-up.
Acute TIN is characterized by the presence of inflammatory infiltrates and oedema within the interstitium, usually associated with an acute deterioration in renal function. It is found in around 15–30 % of biopsies in adults with AKI, and of course, this is likely to be an underestimation, as many patients with typical features are not subjected to a biopsy [4]. The aetiology and clinical presentation of TIN in the paediatric setting has not been described very often, as it is a rare condition, which may require a renal biopsy to make a definitive diagnosis, especially in atypical cases. The current series therefore represents a preselected group of cases undergoing renal biopsy, by definition, representing either clinically atypical or severe cases.
Drugs, in particular antibiotics and NSAIDs, are the most commonly identified causes of TIN in the literature, accounting for 75–90 % of cases [8, 10, 11]. In our series of children with TIN, almost half had received a medication (including non-steroidal anti-inflammatory drugs, antibiotics, H2 blockers, proton pump inhibitors, aspirin and paracetamol), and 30 % had had a recent infection. It is of course difficult to define the cause of TIN in patients with previous infections who have been given antibiotic treatment.
No identifiable predisposing factor was found in around half of the children in our series, if drug use up to 12 weeks before presentation was considered. This is significantly less common compared with other studies where a likely cause of the TIN has been found in the vast majority (>90 %) of cases [8, 10–12]. We can only speculate about the reason for this difference, but it is most likely simply that the majority of patients with suspected TIN with a clear suggested predisposing cause are managed clinically and do not undergo biopsy if their kidney function improves on withdrawal of the drug.
Uveitis with TIN, TINU syndrome, accounts for 4 % of TIN in adults [1, 5], whereas in this series, 65 % of the 23 patients who received an ophthalmology review showed uveitis. Similarly, a recent Finnish case series reported uveitis in 84 % of children with TIN [13], and such patients are less likely to have any other identifiable cause [14]. The ocular lesions are bilateral in 77 % of cases [15]. The pathogenesis is not known, but there is an association with certain human leukocyte antigen types [16]. The outcome seems to be generally good [14].
The treatment of TIN is based on clinical experience and data from case series. The most common approach is corticosteroid therapy. Buysen et al. treated 10 adult patients who had not improved spontaneously on drug discontinuation from a larger group of 27 patients [17]. All 10 showed improvement in renal function and 6 recovered fully [17]. However, in another report, there was no difference in outcome between adult patients who were treated and those who were not treated with prednisolone [8]. In our study all children but 1 received steroid treatment [11].
Only 10 of the 27 children in this series regained normal kidney function, despite active treatment. This outcome is significantly worse than those reported from other case series. For example, 20 children from two series combined reported that all but 1 recovered normal kidney function [12, 18]. In adults, a 60 % recovery of kidney function has been reported [10]. Furthermore, 2 of our children relapsed, a feature that is uncommon in other case series.
In conclusion, we describe a large group of children with biopsy-confirmed TIN in whom a defined cause of the disease was less common than previously reported. Nearly all children required treatment with prednisolone. A new finding is that as many as 60 % of the children showed signs of CKD with impaired kidney function and increased excretion of low molecular weight urine proteins at follow-up.
References
Kodner CM, Kudrimoti A (2003) Diagnosis and management of acute interstitial nephritis. Am Fam Physician 67:2527–2534
Schwarz A, Krause PH, Kunzendorf U, Keller F, Distler A (2000) The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 54:179–190
Jahnukainen T, Ala-Houhala M, Karikoski R, Kataja J, Saarela V, Nuutinen M (2011) Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatr Nephrol 26:291–299
Praga M, Gonzalez E (2010) Acute interstitial nephritis. Kidney Int 77:956–961
Ulinski T, Sellier-Leclerc AL, Tudorache E, Bensman A, Aoun B (2012) Acute tubulointerstitial nephritis. Pediatr Nephrol 27:1051–1057
Raza MN, Hadid M, Keen CE, Bingham C, Salmon AH (2012) Acute tubulointerstitial nephritis, treatment with steroid and impact on renal outcomes. Nephrology (Carlton) 17:748–753
Timmermans SA, Huitema JJ, Wirtz JJ (2013) Keep an eye out for tubulo-interstitial nephritis. Neth J Med 71:523–525
Clarkson MR, Giblin L, O’Connell FP, O’Kelly P, Walshe JJ, Conlon P, O’Meara Y, Dormon A, Campbell E, Donohoe J (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19:2778–2783
Gonzalez CC, Bitsori M, Tullus K (2007) Progression of chronic renal failure in children with dysplastic kidneys. Pediatr Nephrol 22:1014–1020
Baker SB, Williams RT (1963) Acute interstitial nephritis due to drug sensitivity. Br Med J 1:1655–1658
Gonzalez E, Gutierrez E, Galeano C, Chevia C, de Sequera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, Goicoechea M, Quereda C, Olea T, Bouarich H, Hernández Y, Segovia B, Praga M, Grupo Madrileño De Nefritis Intersticiales (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940–946
Ellis D, Fried WA, Yunis EJ, Blau EB (1981) Acute interstitial nephritis in children: a report of 13 cases and review of the literature. Pediatrics 67:862–870
Saarela V, Nuutinen M, Ala-Houhala M, Arikoski P, Ronnholm K, Jahnukainen T (2013) Tubulointerstitial nephritis and uveitis syndrome in children: a prospective multicenter study. Ophthalmology 120:1476–1481
Mackensen F, Billing H (2009) Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol 20:525–531
Mandeville JT, Levinson RD, Holland GN (2001) The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46:195–208
Levinson RD (2008) Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin 48:51–59
Buysen JG, Houthoff HJ, Krediet RT, Arisz L (1990) Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant 5:94–99
Greising J, Trachtman H, Gauthier B, Valderrama E (1990) Acute interstitial nephritis in adolescents and young adults. Child Nephrol Urol 10:189–195
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Howell, M., Sebire, N.J., Marks, S.D. et al. Biopsy-proven paediatric tubulointerstitial nephritis. Pediatr Nephrol 31, 1625–1630 (2016). https://doi.org/10.1007/s00467-016-3374-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-016-3374-9